Announced
Completed
Kinnevik led a $51m Series B1 round in Enveda Biosciences.
Synopsis
Kinnevik, an investment company, led a $51m Series B1 round in Enveda Biosciences, a drug discovery and development company, with participation from Henry Kravis, FPV, True Ventures, and Wireframe.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.